CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
Net loss	$ (13,954,415)	$ (16,196,318)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,993,395	1,973,982
Non-cash lease expense	4,383	9,545
Share-based payments for services	547,893	285,722
Equity-based compensation	2,816,449	3,436,119
Common stock contributed to 401(k) plan	102,392	105,043
(Increase)/decrease in assets:
Prepaid expenses	(30,996)	180,222
Supplies used for R&D and manufacturing	240,067	170,434
Deposits	(11,884)	(2,354,723)
Increase/(decrease) in liabilities:
Accounts payable	(896,939)	102,841
Accrued expenses	59,818	111,515
Due to employees	194,363	37,798
Net cash used in operating activities	(9,415,608)	(12,137,820)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(51,650)	(165,032)
Expenditures for patent costs	(13,211)	0
Net cash used in investing activities	(64,861)	(165,032)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	12,730,000	0
Payments of stock issuance costs	(1,218,937)	(9,010)
Proceeds from the exercise of warrants	0	447,291
Payments on obligations under finance leases	(867,008)	(761,223)
Net cash provided by (used in) financing activities	10,644,055	(322,942)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,163,586	(12,625,794)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	4,145,735	22,672,138
CASH AND CASH EQUIVALENTS, END OF PERIOD	5,309,321	10,046,344
Property and equipment purchases included in current liabilities	0	176,743
Assets purchased under finance leases	20,797	0
Finance lease obligation included in accounts payable	522	1,402
Consulting services paid with issuance of common stock	583,177	192,258
Accrued consulting services to be paid with common stock	165,000	165,000
Financing costs included in current liabilities	46,616	0
Cash paid for interest	$ 480,044	$ 547,765